Trials / Completed
CompletedNCT01956799
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
Identification of Mechanisms in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Fondazione Italiana Sindromi Mielodisplastiche-ETS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the molecular mechanism underlying the erythroid response observed in some patients with myelodysplasia, myelofibrosis and aplastic anemia treated with Deferasirox or Deferoxamina.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2018-07-01
- Completion
- 2019-12-01
- First posted
- 2013-10-08
- Last updated
- 2023-02-15
Locations
20 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01956799. Inclusion in this directory is not an endorsement.